Ludovico Abenavoli

Summary

Affiliation: Magna Graecia University
Country: Italy

Publications

  1. ncbi [Primary biliary cirrhosis: therapeutic options]
    Ludovico Abenavoli
    Unità Operativa Fisiopatologia Digestiva, Dipartimento di Medicina Sperimentale e Clinica, Università Magna Graecia, Catanzaro
    Recenti Prog Med 100:417-23. 2009
  2. ncbi Celiac disease: from gluten to skin
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Graecia, Viale Europa, 88100, Catanzaro, Italy
    Expert Rev Clin Immunol 5:789-800. 2009
  3. doi Milk thistle in liver diseases: past, present, future
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy
    Phytother Res 24:1423-32. 2010
  4. ncbi Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Viale Europa, 88100, Catanzaro, Italy
    Rev Recent Clin Trials 9:134-40. 2014
  5. ncbi Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease
    L Abenavoli
    Department of Health Science, University Magna Græcia, Catanzaro, Italy
    Panminerva Med 56:189-93. 2014
  6. pmc The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Gracia of Catanzaro, Catanzaro, Italy
    Hepat Mon 11:240-6. 2011
  7. ncbi Probiotics in non-alcoholic fatty liver disease: which and when
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Catanzaro Italy
    Ann Hepatol 12:357-63. 2013
  8. doi Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Viale Europa Germaneto, 88100 Catanzaro, Italy Electronic address
    Med Hypotheses 81:913-5. 2013
  9. pmc Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)
    C Torti
    Unit of Infectious Diseases, University Magna Graecia, Catanzaro, Italy
    BMC Infect Dis 12:S9. 2012
  10. doi A pathogenetic link between non-alcoholic fatty liver disease and celiac disease
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Viale Europa, 88100, Catanzaro, Italy
    Endocrine 43:65-7. 2013

Collaborators

Detail Information

Publications23

  1. ncbi [Primary biliary cirrhosis: therapeutic options]
    Ludovico Abenavoli
    Unità Operativa Fisiopatologia Digestiva, Dipartimento di Medicina Sperimentale e Clinica, Università Magna Graecia, Catanzaro
    Recenti Prog Med 100:417-23. 2009
    ..Liver transplantation is usually an option for PBC patients with severe liver failure...
  2. ncbi Celiac disease: from gluten to skin
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Graecia, Viale Europa, 88100, Catanzaro, Italy
    Expert Rev Clin Immunol 5:789-800. 2009
    ..The opportunity to evaluate the possible presence of CD in patients affected by skin disorders is discussed...
  3. doi Milk thistle in liver diseases: past, present, future
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy
    Phytother Res 24:1423-32. 2010
    ..Silymarin has been used to treat alcoholic liver disease, acute and chronic viral hepatitis and toxin-induced liver diseases...
  4. ncbi Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Viale Europa, 88100, Catanzaro, Italy
    Rev Recent Clin Trials 9:134-40. 2014
    ..In this review we describe the role of these adipokines and cytokines in the pathogenesis of NAFLD. We comment on their potential use as non-invasive biomarkers of steatosis and fibrosis, and their potential therapeutic role. ..
  5. ncbi Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease
    L Abenavoli
    Department of Health Science, University Magna Græcia, Catanzaro, Italy
    Panminerva Med 56:189-93. 2014
    ....
  6. pmc The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Gracia of Catanzaro, Catanzaro, Italy
    Hepat Mon 11:240-6. 2011
    ..Based on our results, weight-based doses of RBV are advantageous for genotype 1-infected patients, but its success in genotype 2- and 3-infected patients is unknown, particularly for shorter treatment durations...
  7. ncbi Probiotics in non-alcoholic fatty liver disease: which and when
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Catanzaro Italy
    Ann Hepatol 12:357-63. 2013
    ..However, the species with higher efficacy in this disease are not identified. The present review focuses on the role of gut-liver axis in the pathogenesis, and on the potential therapeutic role of probiotics in the managing of NAFLD...
  8. doi Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Viale Europa Germaneto, 88100 Catanzaro, Italy Electronic address
    Med Hypotheses 81:913-5. 2013
    ..If this correlation is confirmed, the H. pylori treatment may represent an option in the clinical management of liver steatosis. ..
  9. pmc Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)
    C Torti
    Unit of Infectious Diseases, University Magna Graecia, Catanzaro, Italy
    BMC Infect Dis 12:S9. 2012
    ..The final objective is to assist in improving care delivery and inform Public Health Authorities on how to optimize resource allocation in this area...
  10. doi A pathogenetic link between non-alcoholic fatty liver disease and celiac disease
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Viale Europa, 88100, Catanzaro, Italy
    Endocrine 43:65-7. 2013
    ....
  11. doi [Drug-induced liver injury]
    Ludovico Abenavoli
    Dipartmento di Scienze della Salute, Università Magna Græcia, Catanzaro
    Recenti Prog Med 103:79-84. 2012
    ..A therapeutic approach is efficacy only in few cases. When a drug-induced liver injury is suspected, cessation of the drug is the first step in their management...
  12. ncbi Transient elastography in non-alcoholic fatty liver disease
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia of Catanzaro, Italy
    Ann Hepatol 11:172-8. 2012
    ..This review focuses on practical issues in the use of LSM in the NAFLD patients and suggests areas for further research and development...
  13. pmc No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease
    Tiziana Larussa
    Department of Health Science, University of Catanzaro Magna Graecia, 88100 Catanzaro, Italy
    World J Gastroenterol 18:1622-7. 2012
    ..To investigate risk factors for low bone mineral density (BMD) in celiac disease (CD) patients, focusing on circulating autoantibodies against osteoprotegerin (OPG)...
  14. doi Enhanced Expression of Indoleamine 2,3-Dioxygenase in Helicobacter pylori-Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production
    Tiziana Larussa
    Department of Health Science, University of Catanzaro Magna Graecia, Catanzaro, Italy
    Helicobacter 20:41-8. 2015
    ..Indoleamine 2,3 dioxygenase (IDO) interferes with immune responses. Host immune response against Helicobacter pylori is involved in the persistence of the infection and its related diseases...
  15. doi Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
    Ludovico Abenavoli
    Ludovico Abenavoli, Valentina Peta, Department of Health Sciences, University Magna Græcia, 88100 Catanzaro, Italy
    World J Gastroenterol 20:15233-40. 2014
    ..A therapeutic strategy to improve IR and liver steatosis and subsequently the response to antiviral treatment in these patients is warranted. ..
  16. pmc Bone mineralization in celiac disease
    Tiziana Larussa
    Department of Health Science, University of Catanzaro Magna Graecia, University Campus of Germaneto, Viale Europa, 88100 Catanzaro, Italy
    Gastroenterol Res Pract 2012:198025. 2012
    ..Furthermore, additional information on the role of nutritional supplements and alternative therapies is needed...
  17. doi High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease
    Tiziana Larussa
    Department of Health Science, University of Catanzaro Magna Graecia, Catanzaro, Italy
    Eur J Intern Med 23:273-7. 2012
    ..The aim of this study was to investigate TPMT genotype and phenotype status in patients with inflammatory bowel diseases (IBD)...
  18. doi Short-term therapy with celecoxib and lansoprazole modulates Th1/ Th2 immune response in human gastric mucosa
    Tiziana Larussa
    Dipartimento di Medicina Sperimentale e Clinica Dipartimento di Scienze Mediche, Università di Catanzaro Magna Graecia, Catanzaro, Italy
    Helicobacter 15:449-59. 2010
    ..T-cell immune response plays a role in Helicobacter pylori-induced pathogenesis. This study evaluated effects of celecoxib and lansoprazole on T-helper (Th) 1 and Th2 immune response in human gastric mucosa...
  19. ncbi Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia of Catanzaro, Italy
    Ann Hepatol 12:152-5. 2013
    ....
  20. doi Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
    Ludovico Abenavoli
    Ludovico Abenavoli, Valentina Peta, Department of Health Sciences, University Magna Graecia, Campus Germaneto, 88100 Catanzaro, Italy
    World J Gastroenterol 20:16831-40. 2014
    ..New evidence supports the idea that the Mediterranean diet, associated with physical activity and cognitive behaviour therapy, may have an important role in the prevention and the treatment of NAFLD. ..
  21. pmc Pharmacotherapy of acute alcoholic hepatitis in clinical practice
    Ludovico Abenavoli
    Ludovico Abenavoli, Department of Health Sciences, University Magna Graecia, Campus Germaneto, 88100 Catanzaro, Italy
    World J Gastroenterol 20:2159-67. 2014
    ..Liver transplantation is a possible therapeutic option for severe AH. Among the anti-craving medications able to improve abstinence rate, baclofen seems to be effective and safe in the alcoholic patients affected by severe liver damage. ..
  22. ncbi Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series
    Ludovico Abenavoli
    Department of Health Sciences, University Magna Græcia, Catanzaro, Italy
    Ann Hepatol 14:121-6. 2015
    ....
  23. doi Phytotherapeutic approach to alcohol dependence: new old way?
    Ludovico Abenavoli
    Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy
    Phytomedicine 16:638-44. 2009
    ..The present review summarizes the findings of the effects of phytotherapy in alcohol addiction...